Ultralife Q2 Adj $0.22 Beats $0.14 Estimate, Sales $42.98M Beat $42.00M Estimate
Ultralife Q2 Adj $0.22 Beats $0.14 Estimate, Sales $42.98M Beat $42.00M Estimate
Ultralife第二季度調整後每股盈利0.22美元，超過0.14美元的預期，銷售額4298萬美元，超過4200萬美元的預期。
Ultralife (NASDAQ:ULBI) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.14 by 57.14 percent. This is a 1200 percent increase over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $42.98 million which beat the analyst consensus estimate of $42.00 million by 2.34 percent. This is a 34.68 percent increase over sales of $31.92 million the same period last year.
Ultralife（納斯達克股票代號：ULBI）報告每股收益0.22美元，比分析師預期的0.14美元高出57.14％。這相比去年同期每股虧損0.02美元有了1200％的增長。公司第一季度銷售額爲42.98百萬美元，擊敗分析師預期的42.00百萬美元，增長2.34％。與去年同期3,192萬美元的銷售額相比，這是34.68％的增長。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。